Finzati - Logo
ALGN logo

Align Technology, Inc.

ALGN • Medical - Devices
$151.00
▲ +0.50 (+0.34%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$10.78B
Growth
27.6%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 10.2%Positive free cash flow · 6.77Consistent free cash flow · 5/5Manageable debt level · 0.03Healthy liquidity · 1.36
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:30 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$151.00
Change0.34%
Shares Out71.63M
Market Cap$10.78B
Enterprise Value$9.76B
52W Range122.00 - 200.44
Beta1.67
P/E26.06
P/S2.60
P/B2.55
P/FCF13.43
EV/Sales2.36

Investment DNA

How strong this company looks for long-term investors

66
out of 100
Business Quality
Margins, moat, returns
60/100
Financial Strength
Debt, cash, stability
67/100
Growth Potential
Revenue and expansion
33/100
Price Attractiveness
Cheap or expensive today
68/100
Why this score▼
Stable or improving margins · 10.2%Positive free cash flow · 6.77Consistent free cash flow · 5/5Manageable debt level · 0.03Healthy liquidity · 1.36Negative growth trend

Analyst view

Analyst sentiment and price target

ALGN
Analyst sentiment
Based on 33 analyst votes · 2026-10-20
80/100
Bullish
Bullish
22
Hold
9
Bearish
2
Price Target
2026-08-07
Low
$188.00
Mean
$203.50
Median
$200.00
High
$235.00

Company Overview

IPO: 1/30/2001
Industry: Medical - Devices
P/B i: 2.55
Debt / Equity i: 0.03
Operating Margin: 15.27%
Net Margin: 10.17%
ROE i: -
ROIC: -

Financial Health

Score13 / 20
Debt / Equity: 0.03
Current Ratio: 1.36
Quick Ratio: 1.24
Status: Good

Insider Transactions

Recent executive and insider activity

MORROW GEORGE J
Transaction: 05/20/2026
SELL
Change
-1,745
Price
Not reported
Filing
05/22/2026
Type
SELL
MORROW GEORGE J
Transaction: 05/20/2026
BUY
Change
+1,745
Price
Not reported
Filing
05/22/2026
Type
BUY
Conroy Kevin T
Transaction: 05/20/2026
SELL
Change
-1,745
Price
Not reported
Filing
05/22/2026
Type
SELL